Stocks · Health care · Biological Products, (No Diagnostic Substances)

Atara Biotherapeutics, Inc.

ATRA Clue Score62
United States Fiscal year ends December CIK 0001604464 Results filed 12 Aug 2026

What the insiders did Net buying

By person

16 insiders · 22 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
EcoR1 Capital, LLC entity
10% owner
$4.74M (1)
—
+$4.74M
1,552,000
15.46%
$14.90M
+48.6%
Panacea Innovation Ltd entity
10% owner
—
$3.65M (2)
−$3.65M
1,011,000
10.07%
$9.71M
−1.2%
Brian N Cherry
Director
$999.99K (1)
—
+$999.99K
166,486
1.66%
$1.60M
+334.5%
AnhCo Nguyen
President and CEO
—
$142.40K (8)
−$142.40K
132,775
1.32%
$1.27M
+67.8%
Yanina Grant-Huerta
Chief Accounting Officer
—
$56.52K (8)
−$56.52K
49,636
0.4945%
$476.51K
+25.1%
Adiumentum Capital Fund I LP entity
Director
—
—
—
1,209,395
12.05%
$11.61M
+6.7%
Redmile Group, LLC entity
Director
—
—
—
636,852
6.34%
$6.11M
+44.2%
Pascal Touchon
Director
—
—
—
77,955
0.7766%
$748.37K
+11.2%
Eric J Hyllengren
Former EVP, CFO & COO
—
—
—
56,231
0.5602%
$539.82K
+127.1%
William K Heiden
Director
—
—
—
34,188
0.3406%
$328.20K
+138.1%
Carol Giltner Gallagher
Director
—
—
—
33,012
0.3289%
$316.92K
+31.1%
Matthew K Fust
Director
—
—
—
30,188
0.3007%
$289.80K
+191.4%
Jill Henrich
EVP, Chief Regulatory Officer
—
—
—
18,679
0.1861%
$179.32K
−9.9%
Maria Grazia Roncarolo
Director
—
—
—
17,368
0.1730%
$166.73K
+82.1%
Ameet Mallik
Director
—
—
—
16,928
0.1686%
$162.51K
+86.0%
Gregory Austin Ciongoli
Director
—
—
—
12,000
0.1195%
$115.20K
—